title: Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report.
authors.affiliation: Department of Oncology, University of Messina, Messina, Italy. pitini@ciaoweb.it
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Pitini
authors.forename: Diana
authors.initials: D
authors.lastname: Teti
authors.forename: Carmela
authors.initials: C
authors.lastname: Arrigo
authors.forename: Maria
authors.initials: M
authors.lastname: Righi
mesh_terms: D000368:Aged; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D017252:CD3 Complex; D004804:Eosinophils / Q000473:pathology; D005260:Female; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D017252:CD3 Complex; D000074323:Alemtuzumab